OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. Multiple strategies are employed to antibody titer, comprising process parameter optimization, media optimization, and adoption of perfusion systems. Fine-tuning media composition plays a cruci